科美诊断
(688468)
| 流通市值：29.80亿 | | | 总市值：29.80亿 |
| 流通股本：4.01亿 | | | 总股本：4.01亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 111,390,688.04 | 445,340,815.75 | 345,267,780.87 | 219,216,437.67 |
| 营业收入 | 111,390,688.04 | 445,340,815.75 | 345,267,780.87 | 219,216,437.67 |
| 二、营业总成本 | 74,155,506.56 | 306,895,304.46 | 227,457,502.06 | 150,245,582.34 |
| 营业成本 | 24,779,116.8 | 109,723,497.6 | 85,178,337.59 | 54,714,345.74 |
| 税金及附加 | 1,192,309.16 | 5,351,879.74 | 4,187,831.46 | 2,677,357.77 |
| 销售费用 | 19,434,431.16 | 92,273,144.95 | 65,759,240.53 | 43,896,574.77 |
| 管理费用 | 11,803,807.52 | 40,514,353.27 | 29,827,971.8 | 20,061,900.39 |
| 研发费用 | 18,615,108.51 | 65,767,632.46 | 47,237,479.89 | 31,775,488.79 |
| 财务费用 | -1,669,266.59 | -6,735,203.56 | -4,733,359.21 | -2,880,085.12 |
| 其中:利息费用 | 274,830.26 | 472,005.12 | 170,475.86 | 133,476.44 |
| 其中:利息收入 | 1,954,278.19 | 7,269,690.91 | 4,887,306.82 | 2,926,422.27 |
| 加:投资收益 | 4,231,301.1 | 14,770,998.19 | 12,185,249.35 | 9,783,991.39 |
| 资产处置收益 | 214,510.06 | 177,878.69 | 118,157.46 | 16,335.82 |
| 资产减值损失(新) | -8,393.28 | -3,634,930.65 | -2,088,949.41 | -1,624,392.45 |
| 信用减值损失(新) | 181,109.54 | 413,639.36 | 255,722.8 | 289,434 |
| 其他收益 | 762,454.1 | 16,112,986.24 | 8,228,335.25 | 8,198,335.25 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 42,616,163 | 166,286,083.12 | 136,508,794.26 | 85,634,559.34 |
| 加:营业外收入 | 82,638.51 | 103,434.7 | 98,638.14 | 90,354.75 |
| 减:营业外支出 | 414,693.32 | 269,811.68 | 264,935.18 | 73,021.19 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 42,284,108.19 | 166,119,706.14 | 136,342,497.22 | 85,651,892.9 |
| 减:所得税费用 | 3,891,600.79 | 18,746,188.41 | 16,104,133.24 | 9,020,172.25 |
| 六、净利润 | 38,392,507.4 | 147,373,517.73 | 120,238,363.98 | 76,631,720.65 |
| 持续经营净利润 | 38,392,507.4 | 147,373,517.73 | 120,238,363.98 | 76,631,720.65 |
| 归属于母公司股东的净利润 | 38,392,507.4 | 147,373,517.73 | 120,238,363.98 | 76,631,720.65 |
| (一)基本每股收益 | 0.1 | 0.37 | 0.3 | 0.19 |
| (二)稀释每股收益 | 0.1 | 0.37 | 0.3 | 0.19 |
| 九、综合收益总额 | 38,392,507.4 | 147,373,517.73 | 120,238,363.98 | 76,631,720.65 |
| 归属于母公司股东的综合收益总额 | 38,392,507.4 | 147,373,517.73 | 120,238,363.98 | 76,631,720.65 |
| 公告日期 | 2024-04-30 | 2024-04-30 | 2023-10-31 | 2023-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |